| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/12/2011 | CA2408956C Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 07/12/2011 | CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 07/12/2011 | CA2393200C Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 07/12/2011 | CA2373972C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 07/12/2011 | CA2312274C Isolated dna encoding human h3 histamine receptor |
| 07/12/2011 | CA2302874C Jnk3 modulators and methods of use |
| 07/12/2011 | CA2277850C Genetic alterations associated with cancer |
| 07/12/2011 | CA2162262C Methods for treating muscle diseases and disorders |
| 07/07/2011 | WO2011082231A1 Compositions and methods for promoting epithelialization and wound closure |
| 07/07/2011 | WO2011082081A1 Compositions including pyruvate for companion animals and methods of use thereof |
| 07/07/2011 | WO2011082080A1 Compositions including pyruvate for companion animals and methods of use thereof |
| 07/07/2011 | WO2011081942A1 Activation and activators of sirt5 |
| 07/07/2011 | WO2011080488A1 Pharmaceutical composition for treating alcohol dependency |
| 07/07/2011 | WO2011080276A1 Pharmaceutical combinations comprising a dpp-4 inhibitor and a 1,3-diphenylprop-2-en-1-one derivative |
| 07/07/2011 | WO2010136168A3 Continuous administration of cilengitide in cancer treatments |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166202 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha |
| 07/07/2011 | US20110166108 Methods of use related to xerostomia |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110166077 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 07/07/2011 | US20110165262 Reducing drug dependence or addiction |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165093 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/07/2011 | CA2785642A1 Compositions including pyruvate for companion animals and methods of use thereof |
| 07/07/2011 | CA2785641A1 Compositions including pyruvate for companion animals and methods of use thereof |
| 07/06/2011 | EP2341348A1 Methods for detecting cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 07/06/2011 | EP2341346A2 Methods of high-throughput screening for internalizing antibodies and metal-chelating liposomes |
| 07/06/2011 | EP2341143A1 OX2 receptor homolog |
| 07/06/2011 | EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors |
| 07/06/2011 | EP2340856A1 Cosmetic or dermatologic formulation comprising a nutrient medium phase |
| 07/06/2011 | EP2340849A1 Anti-NGF antibodies for the treatment of various disorders |
| 07/06/2011 | EP2340843A1 Methods and compositions to treat myocardial conditions |
| 07/06/2011 | EP2340831A1 HT0712 for the treatment of a cognitive deficit |
| 07/06/2011 | EP2340830A2 Hepatitis C Virus Inhibitors |
| 07/06/2011 | EP2340827A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders using a drug combination |
| 07/06/2011 | EP2340826A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders |
| 07/06/2011 | EP2340825A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders using a neurotransmitter precursor |
| 07/06/2011 | EP2340824A2 Method and preparation for reducing the severity of ADHD and/or motor disorders |
| 07/06/2011 | EP2340042A2 Methods and compositions for the treatment of cancer |
| 07/06/2011 | EP2340023A1 The trpvl antagonist sb-705498 for treating rhinitis |
| 07/06/2011 | EP2340022A1 Combination therapy for tuberculosis |
| 07/06/2011 | EP1696897B1 Compositions for treating diabetes |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1434588B1 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino alkyl -acid derivatives for the treatment of pain |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 07/06/2011 | EP1146906B1 Mucosal delivery system |
| 07/06/2011 | EP0998291B2 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/06/2011 | CN1939540B Medicine composition containing insulin sensibilizer and B-family vatamines |
| 07/06/2011 | CN102119028A Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies |
| 07/06/2011 | CN102114244A Compositions and methods for treating cognitive disorders |
| 07/06/2011 | CN102114000A Co-feeding lipid nano-delivery system for medicine carrying |
| 07/06/2011 | CN101181263B Treatment of respiratory diseases |
| 07/05/2011 | US7973150 Reducing the immunogenicity of fusion proteins |
| 07/05/2011 | US7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/05/2011 | US7973068 Comprises alpha-adrenergic receptor agonist such as clonidine; side effect inhibition |
| 07/05/2011 | US7973064 Administering to a mammal therapeutically effective amount of opiate analgesic and endothelin antagonist for therapy and prophylaxis of pain |
| 07/05/2011 | US7973048 Pharmaceutical composition |
| 07/05/2011 | US7973043 Combination therapy for depression, prevention of suicide, and various medical and psychiatric conditions |
| 07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 07/05/2011 | US7973015 Induction of exon skipping in eukaryotic cells |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | US7972630 Injectable bone mineral substitute material |
| 07/05/2011 | US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids |
| 07/05/2011 | US7972612 Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker |
| 07/05/2011 | US7972595 Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog |
| 07/05/2011 | CA2689080C Treating benign prostate hyperplasia with sarms |
| 07/05/2011 | CA2649844C Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression |
| 07/05/2011 | CA2531445C Method for treating irritable bowel syndrome using laxatives |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2461625C Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary hypertension |
| 07/05/2011 | CA2459172C Bicyclic compound, production and use thereof |
| 07/05/2011 | CA2448025C Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders |
| 07/05/2011 | CA2440160C Antitumor compositions containing taxane derivatives |
| 06/30/2011 | WO2011079249A2 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/30/2011 | WO2011078823A1 Compositions containing salmeterol, fluticasone and cromoglicic acid |
| 06/30/2011 | WO2011078820A1 Pharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid |
| 06/30/2011 | WO2011078818A1 Dry powder combination of tiotropium, a corticosteroid and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078204A1 Prophylactic or therapeutic agent for hyperlipemia, and anti-fatigue agent |
| 06/30/2011 | WO2011077245A2 Compositions |
| 06/30/2011 | WO2011077063A1 Use of polysaccharides for treating stress and anxiety |
| 06/30/2011 | WO2011076946A2 Methods and compositions for the treatment of alzheimer |
| 06/30/2011 | WO2011076843A2 Combination therapy for copd |
| 06/30/2011 | WO2011076841A2 Combination therapy for copd |
| 06/30/2011 | WO2011076596A1 A combination for the treatment of osteoarthritis |
| 06/30/2011 | WO2011075958A1 Use of toll-like receptor-3 agonist in the preparation of medicament for promoting wound healing |
| 06/30/2011 | WO2011056240A3 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 06/30/2011 | US20110160445 Heparin-Binding Growth Factor (HBGF) Polypeptides |
| 06/30/2011 | US20110160299 Composition and method |
| 06/30/2011 | US20110160278 Methods For Selectively Modulating Survivin Apoptosis Pathways |
| 06/30/2011 | US20110160195 Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | CA2785349A1 Combination therapy for copd |
| 06/30/2011 | CA2785321A1 Combination therapy for copd |
| 06/30/2011 | CA2785116A1 A combination for the treatment of osteoarthritis |